| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |